Becton Dickinson and Co vs Quanta Services Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Quanta Services Inc trades at $675 (market cap $99.36B). The key difference: Quanta Services Inc is far larger — about 2× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.34%). Which is the better fit depends on your goals.
| BDX | PWR | |
|---|---|---|
Market Cap | $48.93B | $99.36B |
Sector | Health | Industrials |
52-Week High | $185.39 | $785.24 |
52-Week Low | $138.62 | $372.50 |
Enterprise Value | $65.03B | $105.45B |
Dividend Yield | 2.34% | 0.07% |
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
PWR trades at $671.86, up 0.6% in 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $28.48B in 2025, and the company raised its 2026 outlook, supported by record backlog and infrastructure demand. Analysts show strong buy consensus with a $809.75 price target, though high valuation metrics like a P/E of 76.87 pose concerns.
The outlook is positive due to robust growth and institutional interest, but risks include elevated valuation and competitive pressures. Investment opportunity hinges on execution of raised guidance, while investors face volatility from market reactions to earnings and economic cycles.
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →